Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Neurology | Family Medicine
Disease Category: Postherpetic Neuralgia
Location: United States, CO
New Investigational Medication for Postherpetic Neuralgia (PHN/Shingles)
This is a 12 week treatment study to evaluate the efficacy of two doses of new medication compared to placebo in lowering pain intensity in patients with PHN. There is also a 9 month follow - up period for a total duration of 12 months.
Patient Inclusion Criteria:
- Ages 18-80
- Persistant PHN pain for a minimum of 9 months following the onset of a herpes zoster skin rash (shingles)
- Must be willing to wash out of chronic pain medication for the 12 week treatment period.
Patient Exclusion Criteria:
- Must not have any other neuropathic pain
Alpine Clinical Research Center
1000 Alpine Avenue, Suite 200
Boulder, CO 80304
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these